News FDA advisers back GW's Epidiolex for rare epilepsy UK firm's potential blockbuster on course for approval
News GW files cannabis-based epilepsy drug in EU and US After Sativex disappointment, Epidiolex could transform GW's fortunes.
News NeuroPace brain implant reduces epilepsy seizures in long-te... Data also suggests treatment could improve memory
News UCB recruits Belgian wearables firm for epilepsy study Byteflies' Sensor Dot will help monitor brain, heart and respiration activity.
News GW prepares for 2018 US launch of epilepsy drug But Zynerba's cannabis epilepsy drug fails in phase 2.
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
